新药临床试验期间药物警戒和风险控制研究一:欧美新药临床试验期间药物警戒体系要求对我国申办者的启示
智会静, 冯红云, 周凌芸, 杨建红, 吕心欢, 黎泽琳, 李浩
Research I on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: The Enlightenment of the Requirements for Pharmacovigilance System in Europe and US to Chinese Sponsors
Zhi Huijing, Feng Hongyun, Zhou Lingyun, Yang Jianhong, Lü Xinhuan, Li Zelin, Li Hao
中国药事
.
2022, (6): 616
-623
.
DOI: 10.16153/j.1002-7777.2022.06.003
